Skip to content Carb-X
Carb-X
Boston University
Mobile Menu Toggle navigation
  • Sign Up
  • Contact
  • Twitter
  • LinkedIn
Carb-X
Boston University
Boston University
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Apply Here
    • Applicant Questions
  • Resources
    • CARB-X Connect
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
  • Events
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Apply Here
    • Applicant Questions
  • Resources
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
  • News
    • CARB-X News
    • In the News
    • Antibiotic Resistance
  • Events
  • Contact
  • Legal

Boston University

  • About CARB-X
  • >
  • Boston University

Boston University

Boston University (BU) is the home of CARB-X and the heart of its operations. Based at the BU School of Law, CARB-X is an example of BU’s leadership, collaboration, and engagement with the larger world: a global partnership confronting a dire public health threat – antibiotic-resistant bacteria. Led by Executive Director Kevin Outterson, Austin B. Fletcher Professor at the School of Law, the program facilitates the creation of new vaccines, diagnostics, and therapies around the world to stop the spread of disease – a goal with increasing urgency.

And BU has the expertise to achieve it. A major global research university, BU is a member of the prestigious Association of American Universities. BU’s transformative, cutting-edge research – sponsored annually by hundreds of millions of dollars in awards – addresses society’s most pressing challenges.

“CARB-X’s innovative approach has the best potential to solve the enormous human health problem of increasing resistance to drugs used to treat bacterial infections.”

— Robert A. Brown, President, Boston University

Carb-X

Led by Boston University

Copyright 2023

  • Contact
  • Careers
  • Site Credits
  • Legal
  • Twitter
  • LinkedIn

Copyright 2023